Literature DB >> 4918459

A new agent for the control of spasticity.

R F Jones, D Burke, J E Marosszeky, J D Gillies.   

Abstract

In a preliminary controlled trial, CIBA 34,647-Ba, a gamma aminobutyric acid derivative, was found to be more effective than placebo in reducing spasticity due to spinal injuries. In an uncontrolled trial, 34,647-Ba also appeared more effective than diazepam. The intensity of spasticity was measured electromyographically by the amplitude of the stretch reflex at various velocities, and the results were correlated with those obtained by clinical assessment. 34,647-Ba was effective in both complete and incomplete spinal cord lesions and it is suggested that it has an action at the spinal level. No significant side-effects were encountered.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4918459      PMCID: PMC493501          DOI: 10.1136/jnnp.33.4.464

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  The quadriceps stretch reflex in human spasticity.

Authors:  D Burke; J D Gillies; J W Lance
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-04       Impact factor: 10.154

2.  [On the objectivization of the myotonolitic effect of an aminobutyric acid derivative (Ciba 34647-Ba)].

Authors:  W Birkmayer; W Danielczyk; G Weiler
Journal:  Wien Med Wochenschr       Date:  1967-01-07

3.  Diazepam in the treatment of spasticity. A preliminary quantitative evaluation.

Authors:  I M Evine; P B Jossmann; D G Friend; V DeAngelis; M Kane
Journal:  J Chronic Dis       Date:  1969-06

4.  [A drug with antispastic action on striated muscle. Clinical trial of a derivative of GABA].

Authors:  L Bergamini; A Riccio; B Bergamasco
Journal:  Minerva Med       Date:  1966-08-18       Impact factor: 4.806

5.  On the site of action of diazepam in spasticity in man.

Authors:  J B Cook; P W Nathan
Journal:  J Neurol Sci       Date:  1967 Jul-Aug       Impact factor: 3.181

6.  [Double-blind study on the antispastic effect of beta-94-chlorphenyl)-gamma aminobutyric acid (CIBA) in multiple sclerosis].

Authors:  F Jerusalem
Journal:  Nervenarzt       Date:  1968-11       Impact factor: 1.214

  6 in total
  15 in total

1.  Acute transient cerebral intoxication induced by low doses of baclofen.

Authors:  L G Lazzarino; A Nicolai; F Valassi
Journal:  Ital J Neurol Sci       Date:  1991-06

2.  Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study.

Authors:  G Ochs; A Struppler; B A Meyerson; B Linderoth; J Gybels; B P Gardner; P Teddy; A Jamous; P Weinmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

3.  The effect of intrathecal baclofen on electrical muscle activity in spasticity.

Authors:  H Müller; J Zierski; D Dralle; U Börner; O Hoffmann
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

4.  Effect of baclofen upon monosynaptic and tonic vibration reflexes in patients with spasticity.

Authors:  D L Mclellan; D L Maclellan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-08       Impact factor: 10.154

5.  Editorial: Control of spasticity.

Authors: 
Journal:  Br Med J       Date:  1973-12-29

6.  A phenothiazine derivative in the treatment of spasticity.

Authors:  D Burke; C Hammond; N Skuse; R F Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-05       Impact factor: 10.154

7.  Evaluation of baclofen (Lioresal) for spasticity in multiple sclerosis.

Authors:  D W Hedley; J A Maroun; M L Espir
Journal:  Postgrad Med J       Date:  1975-09       Impact factor: 2.401

Review 8.  Baclofen: a preliminary report of its pharmacological properties and therapeutic efficacy in spasticity.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1974       Impact factor: 9.546

9.  The effect of decerebrate rigidity on the intracranial pressure: an experimental study.

Authors:  S A Tsementzis; F J Gillingham; E R Hitchcock; A Gordon
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

10.  Baclofen in the treatment of spasticity.

Authors:  P Hudgson; D Weightman
Journal:  Br Med J       Date:  1971-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.